Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
2.020
-0.080 (-3.81%)
At close: May 13, 2025, 4:00 PM
2.020
0.00 (0.00%)
Pre-market: May 14, 2025, 6:34 AM EDT

Camp4 Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
49.3264.0438.3883.19
Cash & Short-Term Investments
49.3264.0438.3883.19
Cash Growth
291.24%66.86%-53.86%-
Other Receivables
-0.110.440.68
Receivables
-0.110.440.68
Prepaid Expenses
2.350.930.360.16
Other Current Assets
-1.310.830.38
Total Current Assets
51.6866.3840.0184.41
Property, Plant & Equipment
9.4710.313.3116.79
Other Long-Term Assets
1.621.621.621.35
Total Assets
62.7778.3154.95102.55
Accounts Payable
1.41.211.042.15
Accrued Expenses
1.844.33.013.17
Current Portion of Long-Term Debt
0.090.090.41-
Current Portion of Leases
3.113.093.062.37
Current Unearned Revenue
-0.39--
Other Current Liabilities
-0.540.290.26
Total Current Liabilities
6.449.67.817.95
Long-Term Debt
--0.09-
Long-Term Leases
4.765.568.6410.03
Other Long-Term Liabilities
000-0.04
Total Liabilities
11.215.1616.5317.93
Common Stock
0000
Additional Paid-In Capital
275.76274.936.2333.14
Retained Earnings
-224.19-211.75-159.96-110.67
Total Common Equity
51.5763.14-123.73-77.53
Shareholders' Equity
51.5763.1438.4284.62
Total Liabilities & Equity
62.7778.3154.95102.55
Total Debt
7.968.7312.1812.4
Net Cash (Debt)
41.3655.3126.270.8
Net Cash Growth
1879.90%111.12%-63.00%-
Net Cash Per Share
4.3011.7966.33226.69
Filing Date Shares Outstanding
20.1620.150.460.31
Total Common Shares Outstanding
20.1620.150.460.31
Working Capital
45.2356.7932.2176.46
Book Value Per Share
2.563.13-268.57-248.26
Tangible Book Value
51.5763.14-123.73-77.53
Tangible Book Value Per Share
2.563.13-268.57-248.26
Machinery
-5.574.784.17
Leasehold Improvements
-4.524.524.52
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q